Tozorakimab targets IL-33 upstream of TH2 pathways, cutting COPD exacerbations up to 34% in former smokers, Frank Sciurba, MD ...
A separate poster, drawing on data from the National Institutes of Health's All of Us Research Program, found that women with ...
A small trial found that laughter therapy and pursed-lip breathing reduced reported breathlessness in people with COPD.
3don MSN
AstraZeneca's COPD drug scores two late-stage trial wins as full data boosts blockbuster hopes
The full data reinforces hopes that the drug could be a breakthrough COPD treatment and reach AstraZeneca's peak annual sales ...
A clinical trial for patients with chronic obstructive pulmonary disease (COPD) shows that laughter therapy can reduce ...
New drug shows promise in reducing COPD symptoms in former and current smokers, clinical trials show
A new drug shows promise in reducing the symptoms of COPD, one of the top 10 leading cause of death in the U.S., according to ...
Many patients with chronic obstructive pulmonary disease (COPD) have exacerbations despite receiving standard-of-care inhaled ...
It's well-established that breathing exercises can improve symptoms in COPD by freeing stale air that remains trapped in the ...
A trial found eight weeks of laughter sessions matched a standard breathing exercise.
HealthDay on MSN
Laughter could be great medicine for COPD, study says
Key Takeaways Laughter might be effective medicine against COPDPeople responded to laughter therapy as well as a more ...
Findings show that laughter therapy helps patients with chronic obstructive pulmonary disease (COPD) breathe more easily.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results